Science

Can Novavax’s Coronavirus Vaccine Be Valued?

It does not surprise me that a small capital biotech company like Novavax (NASDAQ: NVAX) skyrocketed when the COVID-19 pandemic began. Millions of people will have to be vaccinated against the virus this year and next. The opportunity in the market is both extensive and risky (as biotech investing is …

Read More »